ATEX.NASDAQAnterix INC

Form 4: Anterix CFO Elena Marquez Trades ATEX Stock

Sentiment:

Insider Transaction Report


Anterix Inc. Chief Financial Officer Elena Marquez reported transactions involving the acquisition and disposition of company stock, alongside the exercise of stock options.

Summary

  • Elena Marquez, Chief Financial Officer of Anterix Inc. (ATEX), engaged in stock transactions on June 17, 2026.
  • Marquez acquired 1,226 shares of common stock at a price of $40 per share.
  • Concurrently, Marquez disposed of 4,291 shares of common stock at a price of $79.50 per share.
  • Following these transactions, Marquez beneficially owns 18,387 shares of common stock directly.
  • Additionally, Marquez exercised a stock option to acquire 1,226 shares of common stock at an exercise price of $40.
  • These stock options vest in three equal annual installments starting October 4, 2025.
  • The total number of derivative securities beneficially owned after the reported transaction is 2,454.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While there's a mix of stock acquisition and disposition, it appears to be a routine management of executive compensation and personal investment rather than a strong signal of impending company performance.

Positives

  • Acquisition of 1,226 shares at a lower price ($40) suggests potential belief in future stock appreciation.
  • Exercise of stock options indicates continued engagement and potential long-term commitment to the company.

Negatives

  • Disposition of 4,291 shares at a higher price ($79.50) could indicate profit-taking or a need for liquidity.
  • The net disposition of shares (4,291 disposed vs. 1,226 acquired) results in a reduction of direct holdings.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance. However, the vesting schedule of stock options extending to 2035 suggests a long-term outlook for the executive.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The reported activity by Anterix Inc.'s CFO is typical for executives managing their compensation and investment in the company. The specific details of acquisition and disposition prices provide insight into executive sentiment regarding the stock's valuation at the time of the trades.

Stakeholder Impact

  • Shareholders: The transactions may be interpreted in various ways, with the acquisition potentially seen as positive and the disposition as a signal of profit-taking or reduced confidence. The net effect on share price is uncertain without further context.
  • Employees: The vesting schedule of stock options for the CFO indicates continued incentive alignment with long-term company performance.
  • Management: The transactions reflect the CFO's personal financial decisions regarding her holdings in Anterix Inc.

Key Dates

DateDescription
06/17/2026Date of earliest transaction and transaction date for stock acquisition and disposition, and stock option exercise.
10/04/2025Vesting commencement date for stock options.
04/03/2035Expiration date of stock options.

Keywords

Form 4, SEC Filing, Insider Trading, Stock Options, Anterix Inc., ATEX, Elena Marquez, Beneficial Ownership, Securities Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.